Blend Therapeutics Inc.
Developing polymeric nanoparticles and novel therapeutics
This article was originally published in Start Up
Prolific entrepreneurs Robert Langer and Omid Farokhzad have formed yet another nanotechnology company. This latest, called Blend Therapeutics Inc., aims to develop new molecular entities, beginning with a novel, platinum drug candidate for cancer, along with a polymeric nanoparticle delivery system for targeting drugs to diseased tissue.